Browsing Tag
Philips
12 posts
Teledyne Technologies to acquire Varex Imaging, adding photon counting X-ray detectors to its imaging portfolio
Teledyne is paying a 52% premium for Varex Imaging, taking the only independent commercial photon counting CT detector supplier as OEMs race to catch Siemens.
Butterfly Network (NYSE: BFLY) AI ultrasound thesis meets the Home Care launch test
Butterfly Network (NYSE: BFLY) beat Q1 with 25% growth, 69% margins and a Midjourney deal. The Home Care launch in Q3 is the next real test.
Why Exor’s leadership changes put capital allocation and company performance in focus
Benoît Ribadeau-Dumas is becoming deputy chief executive officer of Exor as John Elkann tightens oversight of a portfolio spanning Ferrari, Stellantis, Philips, healthcare, luxury, media and investment management.
4DMedical (ASX: 4DX) stock up 7.3% as Mayo Clinic adoption and GSK contract reset lung imaging story
Nuclear medicine VQ scans are a US$1 billion market. 4DMedical (ASX: 4DX) just landed Mayo Clinic, GSK, and Medicare. The question is now scan volume scaling speed.
4DMedical raises (ASX:4DX) $150m to fuel U.S. lung imaging push and expand AI respiratory portfolio
4DMedical raises $150M to scale CT:VQ in the U.S. with minimal dilution. Find out how this move sets the stage for profitability and market leadership.
Philips strengthens image-guided therapy portfolio with SpectraWAVE deal focused on AI coronary assessment
Find out how Royal Philips’ SpectraWAVE acquisition strengthens AI-driven coronary imaging and reshapes image-guided therapy in cardiology.
Why 4DMedical (ASX: 4DX) stock is gaining momentum after A$22.6m option exercise and cash runway boost
4DMedical (ASX: 4DX) raises A$22.6m via option exercise, boosting its cash balance to A$45.5m. Investors eye CT:VQ rollout and RSNA 2025 milestones.
Inside Smart Meter’s iAmbientHealth: the sensor that watches without wearables or cameras
Smart Meter launches iAmbientHealth, a radar-based contactless monitoring sensor predicting patient health risks days in advance.
How 4DMedical’s CT:VQ is rewriting the rules of lung imaging—no radiotracers, no waiting rooms, just pixels
CT:VQ gets FDA clearance—and 4DMedical may be the new standard in lung imaging. Discover how this Aussie SaaS medtech is reshaping respiratory diagnostics.
Why 4DMedical stock is suddenly soaring—and how FDA approval could open a billion-dollar market
4DMedical stock jumps 35% as CT:VQ earns FDA clearance. Find out how this breakthrough in lung imaging is reshaping the USD $1.1B VQ scan market.